Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Nath Bio-Genes

Nath Bio-Genes

BSE: 537291|NSE: NATHBIOGEN|ISIN: INE448G01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 19, 19:44
405.00
-1.3 (-0.32%)
VOLUME 9,854
LIVE
NSE
Oct 19, 19:44
409.20
3.8 (0.94%)
VOLUME 27,429
Download Annual Report PDF Format 2016 | 2015 | 2014

Quarterly Results of Nath Bio-Genes

------------------- in Rs. Cr. -------------------
Jun '17 Mar '17 Dec '16 Sep '16 Jun '16
Net Sales/Income from operations 101.50 50.77 18.17 16.45 84.33
Other Operating Income -- -- -- -- --
Total Income From Operations 101.50 50.77 18.17 16.45 84.33
EXPENDITURE
Consumption of Raw Materials 15.70 4.49 22.02 14.11 19.81
Purchase of Traded Goods 0.18 -- -- -- --
Increase/Decrease in Stocks 37.61 16.72 -16.09 -7.87 17.65
Power & Fuel -- -- -- -- --
Employees Cost 3.84 3.67 3.34 3.88 4.44
Depreciation 0.25 0.40 0.88 0.75 1.00
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 17.58 13.63 2.36 2.42 20.63
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 3.21 11.49 1.34 0.77 2.08
P/L Before Other Inc. , Int., Excpt. Items & Tax 23.12 0.37 4.33 2.40 18.72
Other Income 0.05 0.30 0.09 0.15 0.12
P/L Before Int., Excpt. Items & Tax 23.17 0.67 4.42 2.55 18.84
Interest 2.85 2.91 2.65 1.75 2.34
P/L Before Exceptional Items & Tax 20.32 -2.24 1.77 0.80 16.49
Exceptional Items -- -- -- -- --
P/L Before Tax 20.32 -2.24 1.77 0.80 16.49
Tax 0.28 -0.13 0.60 -- --
P/L After Tax from Ordinary Activities 20.04 -2.11 1.17 0.80 16.49
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items 0.14 -0.07 -- 0.00 --
Net Profit/(Loss) For the Period 20.18 -2.18 1.17 0.80 16.49
Equity Share Capital 16.00 16.00 16.00 16.00 16.00
Reserves Excluding Revaluation Reserves 141.76 121.58 123.77 122.59 121.79
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 12.61 -1.36 0.73 0.50 10.31
Diluted EPS 12.61 -1.36 0.73 0.50 10.31
EPS After Extra Ordinary
Basic EPS 12.61 -1.36 0.73 0.50 10.31
Diluted EPS 12.61 -1.36 0.73 0.50 10.31
Public Share Holding
No Of Shares (Crores) -- -- 0.78 0.78 0.78
Share Holding (%) -- -- 48.72 48.61 48.61
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- 0.64 0.67 0.67
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- 78.17 81.04 81.04
- Per. of shares (as a % of the total Share Cap. of the company) -- -- 40.09 41.65 41.65
b) Non-encumbered
- Number of shares (Crores) -- -- 0.18 0.16 0.16
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- 21.83 18.96 18.96
- Per. of shares (as a % of the total Share Cap. of the company) -- -- 11.19 9.74 9.74
Notes
Source : Dion Global Solutions Limited

Results of Nath Bio-Genes

  • News
  • Results
  • Estimates
  • Analysis
No news.

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for nathbiogenes
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.